STARLING ONCOLOGY INC
STLNNASDAQ🏆 #2377 by market capUS Equity
$6.20▲ $0.04 (+0.57%)
Market closed · at close1h—
24h▲ 0.6%
7d▲ 22.7%
14d▲ 30.3%
30d▼ 1.0%
1y▲ 50.7%
🏦Market Cap
$619M
Small Cap
📈Revenue Growth (YoY)
—
📊Gross Margin
—
💵FCF Margin
—
⚖️P/S Ratio
—
Otter Score
45
Weak
Earnings
Q3 · 2026Reported 2026-08-06Earnings Per Share
Actual
-0.08
Expected
-0.06
miss
−25.00%
YoY +46.70%
Revenue
Actual
$161.28M
Expected
$155.74M
beat
+3.60%
YoY +34.60%
Consensus estimates
Recent quarters
Q3 2026
-0.08
miss
Q2 2026
-0.02
beat
Q3 2025
-0.15
miss
Q2 2025
-0.21
—